Byonanebye, Dathan M.Semitala, Fred C.Katende, JacksonBakenga, AlexArinaitwe, IreneKyambadde, PeterMusinguzi, PatrickAndia Biraro, IreneByakika-Kibwika, PaulineKamya, Moses R.2022-01-122022-01-122020Byonanebye DM, Semitala FC, Katende J, Bakenga A, Arinaitwe I, Kyambadde P, et al. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/μL in a program setting in Uganda. Afri Health Sci. 2020;20(1):132- 41. https://dx.doi.org/10.4314/ahs.v20i1.18https://dx.doi.org/10.4314/ahs.v20i1.18https://nru.uncst.go.ug/xmlui/handle/123456789/1219The World Health Organization recommends antiretroviral therapy (ART) for all HIV-infected patients at all CD4 counts. However, there are concerns that asymptomatic patients may have poorer viral suppression and high attrition. Objectives: We sought to determine attrition and viral suppression among healthy HIV-infected patients initiated on ART in program settings. Methods: This cross-sectional study enrolled ART-experienced patients attending two PEPFAR-supported, high-volume clinics in Kampala, Uganda. Eligible patients were >18 years and had completed at least six months on ART. Participants were interviewed on socio-demographics, ART history and plasma viral load (VL) determined using Abbott Real-time. Predictors of viral suppression (<75 copies/ml) were determined using multivariate logistic regression.enKey populationsViral loadAcquired immunodeficiency syndromeArticle